The TAC is now trialling an Opioid Management Plan to help it better understand the medications prescribed for its clients, and help identify and support those at risk from opioids and other high-risk prescription medicines.
In some cases, medical practitioners will now be asked to complete the Opioid Management Plan for a small number of selected TAC clients who have been prescribed opioids.
The Opioid Management Plan is part of a broader TAC trial initiative to monitor medication delivered to TAC clients and enable us to:
- understand the context of TAC clients’ opioid use and minimise the risk of harm
- offer support to Medical Practitioners in the management of opioids and other high-risk medicines for our clients
- align its approach with SafeScript, which was introduced state-wide on 1 April 2020
- have ongoing compliance with state and federal regulations for the prescription of TAC-funded opioid medications
Over the coming months the TAC will gather feedback from providers, and assess the impact and effectiveness of the Opioid Management Plan, before potential roll-out for all TAC clients prescribed opioid medication.
The Opioid Management Plan is available on the TAC website. Providers will be notified when they are required to complete the plan and will be paid in line with the TAC questionnaires fee schedule (as a Pharmacy questionnaire, item number QU0020).
If you have any questions, please contact us at email@example.com
With the Transport Accident Commission (TAC).
Disclaimer: This article was provided by Transport Accident Commission. While every effort has been made to ensure the information is accurate, North Western Melbourne Primary Health Network does not warrant or represent the accuracy, currency and completeness of any information or material included within.